GlassScriptPhysician profile
Harrison K Pinchot
NPI 1871563726
$1,774.12
in general payments reported to CMS, 2019-2025
15 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $767 · 2020: $617 · 2021: $390.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $520.09 | 2019-2021 | |
| Collegium Pharmaceutical, INC. | $330.10 | 2019-2021 | |
| Boston Scientific Corporation | $150.03 | 2019 | |
| Scilex Pharmaceuticals INC. | $126.11 | 2019-2021 | |
| Horizon Therapeutics Plc | $114.54 | 2020 | |
| Grt US Holding, INC. | $111.94 | 2020-2021 | |
| Si-Bone, INC. | $100.00 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $97.04 | 2019-2020 | |
| Daiichi Sankyo INC. | $62.45 | 2019 | |
| Sentynl Therapeutics, INC. | $58.22 | 2019 | |
| Redhill Biopharma INC. | $34.89 | 2020 | |
| Abbvie INC. | $23.41 | 2021 | |
| Pfizer INC. | $21.00 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $12.28 | 2019 | |
| Electronic Waveform Lab, INC. | $12.02 | 2021 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Harrison Pinchot listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.